Carbohydrate-based therapeutics

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 6, 2004, Pages 691-702

  Osborn, Helen M I ^a   Evans, Phillip G ^a   Gemmell, Natasha ^b   Osborne, Sadie D ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACEMANNAN; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARBOHYDRATE; CARBOHYDRATE ANTIGEN; CARBOHYDRATE DERIVATIVE; CARRAGAUZE; CARRAVET; CASTANOSPERMINE 6 BUTYRATE; DALTEPARIN; DIBEKACIN; DOSMALFATE; DRG 0202; DROTRECOGIN; GD 0039; GLYCOCONJUGATE; HABEKACIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HYALURONIC ACID; KANAMYCIN; LECTIN; MIGLUSTAT; MONOCLONAL ANTIBODY; OSELTAMIVIR; PERAMIVIR; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PRANDASE; SWAINSONINE; THERATOPE; TOPIRAMATE; TYPHOID VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEVESCA 15; ZANAMIVIR;

BIOMIMETICS; CARBOHYDRATE ANALYSIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; ENZYME REPLACEMENT; ENZYME SYNTHESIS; HUMAN; IMMUNIZATION; INFLUENZA VIRUS A; MOLECULAR INTERACTION; NONHUMAN; REVIEW;

ANTI-INFECTIVE AGENTS; ANTIBODIES, MONOCLONAL; BACTERIAL VACCINES; CARBOHYDRATES; CLINICAL TRIALS; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; GLYCOSAMINOGLYCANS; GLYCOSIDE HYDROLASES; GLYCOSYLTRANSFERASES; HUMANS; LECTINS; POLYSACCHARIDES, BACTERIAL;

EID: 3042695376     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023619     Document Type: Review

References (88)

1. Asano, N., Nash, R. J., Molyneux, R. J., Fleet, G. W. J. (2000) Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron. Asymm. 11: 1645-1681
2. Balfour, J. A., McTavish, D. (1993) Acarbose - an update of its pharmacology and therapeutic use in diabetes-mellitus. Drugs 46: 1025-1054
3. Barchi, J. J. (2000) Emerging roles of carbohydrates and glycomimetics in anticancer drug design. Current Pharm. Des. 6: 485-501
4. Barradell, L. B., Buckley, M. M. (1992) Nadroparin calcium: a review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 44: 858-888
5. Bertozzi, C. R., Kiessling, L. L. (2001) Chemical glycobiology. Science 291: 2357-2364
6. Bitton, R. J., Guthmann, M. D., Gabri, M. R., Carnero, A. J. L., Alonso, D. F., Fainboim, L., Gomez, D. E. (2002) Cancer vaccines: an update with special focus on ganglioside antigens (review). Oncol. Rep. 9: 267-276
7. Brockhausen, I. (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim.. Biophys. Acta 1473: 67-95
8. Cacalano, G., Kays, M., Saiman, L., Prince, A. (1992) Production of the Pseudomonas-aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J. Clin. Invest. 89: 1866-1874
9. Chu, D. T. W. (2001) Anti-infective agents. Curr. Pharm. Design 7: U6 (preface)
10. Coppa, G. V., Gabrielli, O., Giorgi, P., Catassi, C., Montanari, M. P., Varaldo, P. E., Nichols, B. L. (1990) Preliminary-study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 335: 569-571
11. Cox, T. M., Aerts, J. M., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., Giralt, M., Heitner, R., Hollak, C., Hrebicek, M., Lewis, M., Mehta, A., Pastores, G. M., Rolfs, A., Miranda, M. C., Zimran, A. (2003) The role of the iminosugar N-butyldeoxynojirimycin (Miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J. Inherit. Metab. Dis. 26: 513-526
12. Crocker, P. R., Feizi, T. (1996) Carbohydrate recognition systems: functional triads in cell-cell interactions. Curr. Opin. Struct. Biol. 6: 679-691
13. Cunto-Amesty, G., Monzavi-Karbassi, B., Luo, P., Jousheghany, F., Kieber-Emmons, T. (2003) Strategies in cancer vaccine development. Int. J. Parasitol. 33: 597-613
14. Davis, B. G. (2002a) Synthesis of glycoproteins. Chem. Rev. 102: 579-601
15. Davis, B. (2002b) Preparation of enzyme conjugated to carbohydrate moiety which binds to lectin-directed prodrug delivery system. PCT Int. Appl. Patent No. WO02/080980
16. Davis, B. G., Robinson, M. A. (2002) Drug delivery systems based on sugar-macromolecule conjugates. Curr. Opin. Drug Discov. Dev. 5: 279-288
17. Dennis, J. W., Granovsky, M., Warren, C. E. (1999) Glycoprotein glycosylation in cancer progression. Biochim. Biophys. Acta 1473: 21-34
18. Dove, A. (2001) The bittersweet promise of glycobiology. Nature 19: 913-917
19. Duncan, R. (2003) The dawning era of polymer therapeutics. Nature Rev. Drug Discovery 2: 347-360
20. Dunn, C. J., Jarvis, B. (2000) Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease. Drugs 60: 203-237
21. Dwek, R. A., Butters, T. D. (2002) Introduction: glycobiology-understanding the language and meaning of carbohydrates. Chem. Rev. 102: 283-284
22. Egger, S. F., Brown, G. S., Kelsey, L. S., Yates, K. M., Rosenberg, L. J., Talmadge, J. E. (1996) Studies on optimal dose and administration schedule of a hematopoietic stimulatory beta-(1,4)-linked mannan. Int. J. Immunopharmacol. 18: 113-126
23. El Ashry, E. S. H., Rashed, N., Shobier, A. H. S. (2000) Glycosidase inhibitors and their chemotherapeutic value. Pharmazie 55: 251-262
24. Faught, E., Wilder, B. J., Ramsay, R. E., Reife, R. A., Kramer, L. D., Pledger, G. W., Karim, R. M., Barr, A., Fischer, J., Bergen, D., Boor, D., Browne, T., Davenport, J., Dichter, M., Drake, M., Kuzniecky, R., Mamdani, M., McCutchen, C., Naritoku, D., Potolicchio, S., Ramani, V., Ramsay, R., Shinnar, S., So, E., Wilder, B. (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 46: 1684-1690
25. Feizi, T. (1993) Oligosaccharides that mediate mammalian cell-cell adhesion. Curr. Opin. Struct. Biol. 3: 701-710
26. Fleming, D. M. (2003) Zanamivir in the treatment of influenza. Expert Opin. Pharmacother. 4: 799-805
27. Garnett, W. R. (2000) Clinical pharmacology of topiramate: a review. Epilepsia 41: S61-S65
28. Gorelik, E., Galili, U., Raz, A. (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 20: 245-277
29. Goss, P. E., Baptist, J., Fernandes, B., Baker, M., Dennis, J. W. (1994) A Phase-I study of Swainsonine in patients with advanced malignancies. Cancer Res. 54: 1450-1457
30. Goss, P. E., Baptist, J., Fernandes, B., Baker, M., Dennis, J. W., Reid, C. L. (1997) Phase Ib clinical trial of the oligosaccharide processing inhibitor Swainsonine in patients with advanced malignancies. Clin. Cancer Res. 3: 1077-1086
31. Greimel, P., Spreitz, J., Stutz, A. E., Wrodnigg, T. M. (2003) Iminosugars and relatives as antiviral and potential anti-infective agents. Curr. Top. Med. Chem. 3: 513-523
32. Gruner, S. A. W., Locardi, E., Lohof, E., Kessler, H. (2002) Carbohydrate-based mimetics in drug design: Sugar amino acids and carbohydrate scaffolds. Chem. Rev. 102: 491-514
33. Hayden, F. G., Treanor, J. J., Betts, R. F., Lobo, M., Esinhart, J. D., Hussey, E. K. (1996) Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275: 295-299
34. Hewitt, M. C., Snyder, D. A., Seeberger, P. H. (2002) Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis. J. Am. Chem. Soc. 124: 13434-13436
35. Hounsell, E. F., Young, M., Davies, M. J. (1997) Glycoprotein changes in tumours: a renaissance in clinical applications. Clin. Sci. 93: 287-293
36. Kim, Y. J., Varki, A. (1997) Perspectives of the significance of altered glycosylation of glycoproteins in cancer. Glycoconj. J. 14: 569-576
37. Kleist, P., Ehrlich, A., Suzuki, Y., Timmer, W., Wetzelsberger, N., Lucker, P. W., Fuder, H. (1997) Concomitant administration of the alpha-glucosidase inhibitor voglibose (AO-128) does not alter the pharmacokinetics of glibenclamide. Eur. J. Clin. Pharmacol. 53: 149-152
38. Koeller, K. M., Wong, C.-H. (2000) Emerging themes in medicinal glycoscience. Nature Biotechnol. 18: 835-841
39. Koganty, R. R., Reddish, M. A., Longenecker, B. M. (1996) Glycopeptide and carbohydrate based synthetic vaccines for the immunotherapy of cancer. Drug Discovery Today 1: 190-198
40. Kuberan, B., Lech, M. Z., Beeler, D. L., Wu, Z. L. L., Rosenberg, R. D. (2003) Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nature Biotechnol. 21: 1343-1346
41. Kunz, C., Rudloff, S. (1993) Biological functions of oligosaccharides in human-milk. Acta Paediatr. 82: 903-912
42. Lavelle, E. C. (2001) Targeted delivery of drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Sys. 18: 341-386
43. Lee, D. G., Chun, H. J., Yim, D.-S., Choi, S.-M., Choi, J.-H., Yoo, J.-H., Shin, W.-S., Kang, M.-W. (2003) Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model. Antimicrob. Agents Chemother. 47: 3768-3773
44. Lillelund, V. H., Jensen, H. H., Liang, X. F., Bols, M. (2002) Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin. Chem. Rev. 102: 515-553
45. Lis, H., Sharon, N. (1998) Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem. Rev. 98: 637-674
46. Lloyd, K. O. (2000) Carbohydrate vaccines for the immunotherapy of cancer. Drug News Perspect. 13: 463-470
47. Love, K. R., Seeberger, P. H. (2004) Automated solid-phase synthesis of protected tumour-associated antigen and blood group determinant oligosaccharides. Angew. Chem. Int. Ed. Engl. 43: 602-605
48. McAuliffe, J. C., Hindsgaul, O. (1997) Carbohydrate drugs - an ongoing challenge. Chem. Ind. 170-174
49. McEver, R. P. (1997) Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj. J. 14: 585-591
50. Mulvey, G., Kitov, P. I., Marcato, P., Bundle, D. R., Armstrong, G. D. (2001) Glycan mimicry as a basis for novel anti-infective drugs. Biochimie 83: 841-847
51. Musser, J. H., Fugedi, P., Anderson, M. B., Rao, N., Pete, C., Tyrrell, D., Holme, K., Tressler, R. (1996) Carbohydrates as a source of molecular diversity for drug discovery. Drug News Perspect. 9: 133-141
52. Musser, J. H. (2003) Carbohydrate-based therapeutics. In: Abraham, D. J. (ed.) Burger's medicinal chemistry and drug discovery. 6th edn, Volume 2, John Wiley & Sons, New York, pp 203-248
53. Nilsson, M., Norberg, T. (1998a) Synthesis of a spacer-containing nonasaccharide fragment of Streptococcus pneumoniae 19F capsular polysaccharide. J. Chem. Soc. Perkin Trans. 1: 1699-1704
54. Nilsson, M., Norberg, T. (1998b) Solid-phase synthesis of an analog of Haemophilus influenzae type B capsular polysaccharide. J. Carbohydr. Chem. 17: 305-316
55. Nishimura, Y. (2003) gem-Diamine 1-N-iminosugars and related iminosugars, candidate therapeutic agents for tumour metastasis. Curr. Top. Med. Chem. 3: 575-591
56. Noble, S., Spencer, C. M. (1998) Enoxaparin: a review of its clinical potential in the management of coronary artery disease. Drugs 56: 259-272
57. Nygren, P., Larsson, R. (2003) Overview of the clinical efficacy of investigational anticancer drugs. J. Intern. Med. 253: 46-75
58. Orgueira, H. A., Bartolozzi, A., Schell, P., Litjens, R. E. J. N., Palmacci, E. R., Seeberger, P. H. (2003) Modular synthesis of heparin oligosaccharides. Chem Eur J 9: 140-169
59. Pelley, R. P., Strickland, F. M. (2000) Plants, polysaccharides, and the treatment and prevention of neoplasia. Crit. Rev. Oncog. 11: 189-225
60. Peters, C. C. A. M., Evenberg, D., Hoogerhout, P., Käyhty, H., Saarinen, L., van Boeckel, C. A. A., van der Marel, G. A., van Boom, J. H., Poolman, J. T. (1992) Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody-responses to haemophilus-influenzae type-B capsular polysaccharide in mice and monkeys. Infect. Immun. 60: 1826-1833
61. Plante, O. J., Seeberger, P. H. (2003) Recent advances in automated solid-phase carbohydrate synthesis: from screening to vaccines. Curr. Opin. Drug. Discovery. Dev. 6: 521-525
62. Privitera, M. D. (1997) Topiramate: a new antiepileptic drug. Ann. Pharmacother. 31: 1164-1173
63. Samama, M. M., Gerotziafas, G. T. (2002) Evaluation of the pharmacological properties, and clinical results of the synthetic pentasaccharide (fondaparinux). Thromb. Res. 109: 1-11
64. Sapra, P., Allen, T. M. (2003) Ligand-targeted liposomal anti-cancer drugs. Prog. Lipid Res. 42: 439-462
65. Schofield, L., Hewitt, M. C., Evans, K., Siomas, M. A., Seeberger, P. H. (2002) Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418: 785-789
66. Seeberger, P. H., Haase, W. C. (2000) Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries. Chem. Rev. 100: 4349-4394
67. Shigeoka, H., Karsten, U., Okuno, K., Yasutomi, M. (1999) Inhibition of liver metastases from neuraminidase-treated Colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody. Tumor Biol. 20: 139-146
68. Simanek, E. E., McGarver, G. J., Jablonowski, J. A., Wong, C. H. (1998) Selectin-carbohydrate interactions: From natural ligands to designed mimics. Chem. Rev. 98: 833-862
69. Simon, P. M. (1996) Pharmaceutical oligosaccharides. Drug Discovery Today 1: 522-528
70. Singh, R. S., Tiwary, A. K., Kennedy, J. F. (1999) Lectins: sources, activities and applications. Crit. Rev. Biotechnol. 19: 145-178
71. Slovin, S. F., Ragupathi, G., Adluri, S., Ungers, G., Terry, K., Kim, S., Spassova, M., Bornmann, W. G., Fazzari, M., Dantis, L., Olkiewicz, K., Lloyd, K. O., Livingston, P. O., Danishefsky, S. J., Scher, H. I (1999) Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc. Natl Acad. Sci. USA 96: 5710-5715
72. Somers, W. S., Tang, J., Shaw, G. D., Camphausen, R. T. (2000) Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103: 467-479
73. Stapleton, A., Nudelman, E., Clausen, H., Hakomori, S.-I., Stamm, W. E. (1992) Binding of uropathogenic Escherichiacoli R45 to glycolipids extracted from vaginal epithelial-cells is dependent on histoblood group secretor status. J. Clin. Invest. 90: 965-972
74. Tan, K. T., Makin, A., Lip, G. Y. H. (2003) Factor X inhibitors. Exp. Opin. Invest. Drugs 12: 799-804
75. Taylor, D. L., Sunkara, P. S., Liu, P. S., Kang, M. S., Bowlin, T. L., Tyms, A. S. (1991) 6-O-Butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIV. Aids 5: 693-698
76. Turpie, A. G. G., Eriksson, B. I., Bauer, K. A., Lassen, M. R. (2003) New pentasaccharides for the prophylaxis of venous thromboembolism - clinical studies. Chest 124 (Suppl.): 371S-378S
77. Varki, A. (1993) Biological roles of oligosaccharides - all of the theories are correct. Glycobiology 3: 97-130
78. Vichier-Guerre, S., Lo-Man, R., BenMohamed, L., Deriaud, E., Kovats, S., Leclerc, C., Bay, S. (2003) Induction of carbohydrate specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use. J. Pept. Res. 62: 117-124
79. Vogel, P. (2001) Monosaccharide and disaccharide mimics: new molecular tools for biology and medicine. Chimia 55: 359-365
80. Vyas, S. P., Singh, A., Sihorkar, V. (2001) Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit. Rev. Ther. Drug Carrier Syst. 18: 1-76
81. Wang, G. T. (2002) Recent advances in the discovery and development of anti-influenza drugs. Expert Opin. Ther. Pat. 12: 845-861
82. Wilde, M. I., Markham, A. (1997) Danaparoid: a review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs 54: 903-924
83. Wiley, D. C., Skehel, J. J. (1987) The structure and function of the Hemagglutinin membrane glycoprotein of influenza-virus. Annu. Rev. Biochem. 56: 365-394
84. Wirth, M., Fuchs, A., Wolf, M. Ertl, B., Gabor, F. (1998) Lectin-mediated drug targeting: preparation, binding characteristics and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm. Res. 15: 1031-1037
85. Wong, C.-H. (2003) Carbohydrate-based drug discovery. Wiley-VCH, Weinheim
86. Yagi, A., Takeo, S., Yakugaku, Z. (2003) Anti-inflammatory constituents, aloesin and aloemannan in Aloe species and effects of tanshinon VI in Salvia miltiorrhiza on heart. J. Pharm. Soc. Jpn. 123: 517-532
87. Yarema, K. J., Bertozzi, C. R. (1998) Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr. Opin. Chem. Biol. 2: 49-61
88. Zopf, D., Roth, S. (1996) Oligosaccharide anti-infective agents. Lancet 347: 1017-1021